Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Burning Rock Biotech (BNR) Liabilities and Shareholders Equity (2019 - 2025)

Burning Rock Biotech has reported Liabilities and Shareholders Equity over the past 7 years, most recently at $115.7 million for Q4 2025.

  • For Q4 2025, Liabilities and Shareholders Equity fell 6.15% year-over-year to $115.7 million; the TTM value through Dec 2025 reached $460.8 million, down 14.89%, while the annual FY2025 figure was $115.7 million, 4.63% down from the prior year.
  • Liabilities and Shareholders Equity for Q4 2025 was $115.7 million at Burning Rock Biotech, up from $113.5 million in the prior quarter.
  • Over five years, Liabilities and Shareholders Equity peaked at $413.8 million in Q1 2021 and troughed at $113.5 million in Q3 2025.
  • A 5-year average of $216.2 million and a median of $175.6 million in 2023 define the central range for Liabilities and Shareholders Equity.
  • Biggest five-year swings in Liabilities and Shareholders Equity: dropped 5.61% in 2021 and later plummeted 37.62% in 2023.
  • Year by year, Liabilities and Shareholders Equity stood at $356.4 million in 2021, then crashed by 37.37% to $223.2 million in 2022, then tumbled by 35.29% to $144.4 million in 2023, then fell by 14.67% to $123.2 million in 2024, then decreased by 6.15% to $115.7 million in 2025.
  • Business Quant data shows Liabilities and Shareholders Equity for BNR at $115.7 million in Q4 2025, $113.5 million in Q3 2025, and $114.0 million in Q2 2025.